July 18, 2016
The Soviet Biological Weapons Program and Its Legacy in Today’s Russia
In its first Weapons of Mass Destruction (WMD) Case Study, the Center for the Study of Weapons of Mass Destruction (CSWMD) at the National Defense University examined President Richard M. Nixon’s decision, on November 25, 1969, to terminate the U.S. offensive biological weapons program. This occasional paper seeks to explain why the Soviet government, at approximately the same time, decided to do essentially the opposite, namely, to establish a large biological warfare (BW) program that would be driven by newly discovered and powerful biotechnologies. By introducing the innovation of recombinant DNA technology—commonly referred to as genetic engineering—the Soviets were attempting to create bacterial and viral strains that were more useful for military purposes than were strains found in nature.
Oct. 1, 2009
President Nixon’s Decision to Renounce the U.S. Offensive Biological Weapons Program
The nuclear arms race between the United States and the Soviet Union was a prominent feature of the Cold War. A lesser known but equally dangerous element of the superpower competition involved biological weapons (BW), living microorganisms that cause fatal or incapacitating diseases in humans, animals, or plants. By the late 1960s, the United States and the Soviet Union had both acquired advanced BW capabilities. The U.S. biological weapons complex, operated by the U.S. Army Chemical Corps, consisted of a research and development laboratory at Fort Detrick in Maryland, an open-air testing site at Dugway Proving Ground in Utah, and a production facility at Pine Bluff Arsenal in Arkansas that manufactured biological warfare agents and loaded them into bomblets, bombs, and spray tanks.